Philips challenges 'conventional' PET-CT with novel MR technology
VIENNA, Austria — If doctors liked PET-CT, they are going to love PET-MRI. And despite its high cost, doctors like PET-CT a lot, valuing the new insights into the biology of specific tumors offered by this technology that fuses metabolic processes shown by PET images layered over the anatomical references provided by with CT. (Medical Device Daily)
Medical Device Daily's Medical Technology and Pandemic Threats: Swine, Avian and SARS
The only place to find a complete overview of how the med tech sector is responding to the H1N1 pandemic, giving companies a keen outlook into what competitors are doing to assess the market for potential launch of new products.
Political chasm over reform effort remains both deep and wide
A fair number of Americans gathered in front of their TV sets last week, but not to watch Canada vs. the U.S. in Olympic gold-medal hockey clashes or the artistry of South Korean figure skating queen Kim Yu-Na or even the curiously addictive draw of curling. Rather, they had their eyes glued – some for hours on end – to the so-called Healthcare Summit. (MDD Perspectives)
The BB&T interview: John S. Taylor, VP of research for National Venture Capital Association
John S. Taylor is vice president of research at the National Venture Capital Association (NVCA; Arlington, Virginia). He is responsible for developing and overseeing association data and research efforts. The key element in this effort is a research consortium which was created in 1998 involving the NVCA and Venture Economics, now Thomson Reuters. (Biomedical Business & Technology)
